Publications by authors named "E Ayas"
Article Synopsis
- The MONALEESA-7 study is the only phase 3 research on CDK 4-6 inhibitors for premenopausal patients with hormone receptor-positive, HER2 negative metastatic breast cancer, but there is limited data on palbociclib's effectiveness.
- Our multicenter, retrospective study included 319 patients to evaluate the effectiveness of palbociclib and ribociclib in first-line treatment and how dose reduction due to neutropenia affects progression-free survival (PFS).
- Results showed similar median PFS for both drugs (26.83 months for palbociclib and 29.86 months for ribociclib) and no significant impact of dose reduction on effectiveness, with P
α-β SiAlON/TiN composites with nominal composition of α:β = 25:75 were fabricated by microwave sintering. The effect of titanium nitride addition on the phases, microstructure, microwave absorption ability and mechanical properties (Vickers hardness and fracture toughness) of the SiAlON-based composites were studied. Finite Difference Time Domain (FDTD) software was used for the numerical simulation in order to assess the most suitable experimental setup.
View Article and Find Full Text PDF